Business Wire

QC Laboratories, Inc. Awarded Nadcap Certification for Computed Radiography

19.7.2023 14:59:00 EEST | Business Wire | Press release

Share

QC Laboratories, Inc., a leading nondestructive testing and inspection services company, has announced that it has been awarded Nadcap certification for computed radiography (AC7114/10S) by the Performance Review Institute (PRI).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230717661945/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

The Nadcap certification is a highly respected accreditation that recognizes companies that demonstrate exceptional quality and performance in the aerospace industry. QC Laboratories, Inc. has met the rigorous requirements of the Nadcap audit for computed radiography, which includes stringent technical and quality standards, as well as an assessment of the company's personnel, facilities, and processes.

"We are thrilled to have achieved this certification, which reflects our unwavering commitment to providing the highest quality nondestructive testing and inspection services to our customers," said Jose Crespo, General Manager of QC Laboratories, Inc. "With the addition of Nadcap certification for Computed Radiography per ASTM E2033, combined with our powerful 450kV x-ray system, we are better equipped to serve our Nadcap subscriber customers in aerospace & defense, space, and beyond."

Computed radiography is a nondestructive testing method that uses digital imaging technology to produce high-quality images of internal structures and components. This technology enables the detection of defects and discontinuities in materials, such as cracks, porosity, and inclusions, without damaging them.

QC Laboratories, Inc. has had remarkable success in identifying defects in metal additive manufacturing parts using computed radiography. The company has been able to detect defects as small as 25 microns, which is crucial for ensuring the quality and reliability of complex metal parts made from exotic and refractory metals like those used in aircraft and rocket engine components, where high strength and thermodynamics are required.

With the new Nadcap certification for computed radiography (AC7114/10S), QC Laboratories, Inc. is now able to offer computed radiography services that meet the rigorous quality and technical standards of the aerospace industry. This certification further strengthens the company's position as a trusted provider of nondestructive testing and inspection services to customers in a wide range of industries.

About QC Laboratories, Inc.

QC Laboratories, Inc. is a nondestructive testing laboratory in Hollywood, Florida, USA. The company was founded in 1965 and offers various testing services, including nondestructive testing (NDT), chemical processing, and consulting services.

QC Laboratories serves a variety of industries, including aerospace, additive manufacturing, automotive, defense, manufacturing, and consumer products. The laboratory is accredited by the American Society for Nondestructive Testing (ASNT) and is certified by the Federal Aviation Administration (FAA) and Nadcap (Performance Review Institute) for NDT services.

QC Laboratories has a team of experienced nondestructive engineers and technicians using advanced testing equipment and techniques to provide accurate and reliable results. The laboratory is committed to delivering high-quality services and maintaining the highest standards of professionalism and ethics.

For more information about QC Laboratories' new capability for pre-penetrant etching of metal AM parts, please visit www.qclabs.net or contact the laboratory directly.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Althea Lawson
QC Laboratories, Inc.
Phone: (954) 925-0499
Email: info@qclabs.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carta Rearchitects Private Capital Operations with Plugins for Claude29.7.2026 17:01:00 EEST | Press release

Carta, the connected platform and AI-native ecosystem for private capital, today announces broad availability of its suite of Plugins for Claude following the initial launch in April 2026. With more than 1,500 companies and firms already using the plugins, Carta is changing the way private capital teams — from founders to CFOs — fundamentally operate, bringing fund administration, cap table management, and dealflow analytics directly into the spreadsheets, presentations, and workflows they already use every day. "For the last decade, private capital operation teams have been held back by a hidden tax: the constant, manual handoff of data between disconnected systems," said Henry Ward, Carta CEO. "Carta is eliminating that broken loop entirely by embedding intelligence directly into the tools teams already use. We are not waiting for an AI-native future for private capital — it is running on Carta today." Carta didn't just give Claude a pipe to its data. Carta built its private-capital

VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 16:00:00 EEST | Press release

VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre

Grid Dynamics Accelerates Enterprise AI-Native Transformation With Workforce Certification and GAIN Platforms Rollout29.7.2026 16:00:00 EEST | Press release

Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a leading provider of technology consulting, platform and product engineering, and AI-driven digital transformation services, today announced significant momentum in the adoption of its enterprise agentic AI solutions. Organizations across retail, financial services, manufacturing, CPG, and logistics industries are increasingly deploying Grid Dynamics’ agentic AI-native platforms and Forward Deployed Engineering (FDE)-led services to accelerate software delivery, improve operational efficiency, and transform business processes at scale. Grid Dynamics is widely recognized for its enterprise AI expertise and delivery capabilities across Fortune 1000 organizations. Grid Dynamics has partnership agreements with Anthropic and OpenAI to accelerate the adoption of these platforms within enterprises. By the end of October 2026, Grid Dynamics plans to have 90% of its engineers trained and certified on these platforms. Built to suppo

VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 16:00:00 EEST | Press release

VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre

Experian Recognized by Chartis Research for Advancing AI Model Governance in Quantitative Analytics50 202629.7.2026 16:00:00 EEST | Press release

Experian today announced it has been recognized by Chartis Research as the winner in the Model Risk Management Environment category in the Quantitative Analytics50 2026 report. The recognition marks Experian's first appearance in the prestigious ranking and reinforces the company's position as a leading provider of data and AI-driven analytics solutions for regulated financial services organizations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729058148/en/ Chartis Research recognized Experian as the category winner for Model Risk Management Environment in the Quantitative Analytics50 2026 report. "This recognition from Chartis reflects the growing importance of governing AI with the same rigor used to build it," said Vijay Mehta, Chief AI Officer at Experian. "Financial institutions need to scale AI without sacrificing transparency, accountability or regulatory compliance. Our vision is to provide an integrated agenti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye